Drug Repositioning
Approaches and Applications for Neurotherapeutics
Herausgeber: Dudley, Joel; Berliocchi, Laura
Drug Repositioning
Approaches and Applications for Neurotherapeutics
Herausgeber: Dudley, Joel; Berliocchi, Laura
- Gebundenes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Drug Repositioning: Approaches and Applications for Neurotherapeutics reviews history and advances in drug repositioning, with a special focus on therapeutics for nervous system diseases.
Andere Kunden interessierten sich auch für
- Rishi PaliwalNanomedicine, Nanotheranostics and Nanobiotechnology225,99 €
- Yongyuth YuthavongTapping Molecular Wilderness61,99 €
- Global Regulations of Medicinal, Pharmaceutical, and Food Products157,99 €
- Essential Oils167,99 €
- John C. Foreman / Torben Johansen / Alasdair J. Gibb (Hrsg.)Textbook of Receptor Pharmacology202,99 €
- LevineAmorphous Food and Pharmaceutical Systems149,99 €
- Sven Erik JorgensenEcotoxicology and Chemistry Applications in Environmental Management246,99 €
-
-
-
Drug Repositioning: Approaches and Applications for Neurotherapeutics reviews history and advances in drug repositioning, with a special focus on therapeutics for nervous system diseases.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Produktdetails
- Produktdetails
- Verlag: Apple Academic Press
- Seitenzahl: 313
- Erscheinungstermin: 13. Juli 2017
- Englisch
- Abmessung: 229mm x 155mm x 23mm
- Gewicht: 590g
- ISBN-13: 9781482220834
- ISBN-10: 1482220830
- Artikelnr.: 42750693
- Herstellerkennzeichnung
- Libri GmbH
- Europaallee 1
- 36244 Bad Hersfeld
- 06621 890
- Verlag: Apple Academic Press
- Seitenzahl: 313
- Erscheinungstermin: 13. Juli 2017
- Englisch
- Abmessung: 229mm x 155mm x 23mm
- Gewicht: 590g
- ISBN-13: 9781482220834
- ISBN-10: 1482220830
- Artikelnr.: 42750693
- Herstellerkennzeichnung
- Libri GmbH
- Europaallee 1
- 36244 Bad Hersfeld
- 06621 890
Dr. Joel Dudley is associate professor of genetics and genomic sciences and director of biomedical informatics at Mount Sinai School of Medicine, New York (NY, USA). Dr. Laura Berliocchi is associate professor of pharmacology at the Department of Health Sciences, Magna Graecia University (Catanzaro, Italy).
Section I The Rationale and Economics
of Drug Repositioning
Chapter 1 Scientific and Commercial Value of Drug Repurposing
David Cavalla
Chapter 2 Repurposing for Alzheimer's and Parkinson's Diseases: The
Ideas, the Pipeline, the Successes, and the Disappointments
Hermann Mucke
Chapter 3 Contribution of Not-for-Profit Organizations to Drug Repurposing
Bruce Bloom
Section II Repositioning Approaches and
Technologies: From Serendipity to
Systematic and Rational Strategies
Chapter 4 Systematic Drug Repositioning
Spyros N. Deftereos, Aris Persidis, Andreas Persidis,
Eftychia Lekka, Christos Andronis, and Vassilis Virvillis
Chapter 5 Technical Tools for Computational Drug Repositioning
Francesco Napolitano
Chapter 6 RNAi Screening toward Therapeutic Drug Repurposing
Nichole Orr-Burks, Byoung-Shik Shim, Olivia Perwitasari,
and Ralph A. Tripp
Chapter 7 Phenotypic Screening
Christine M. Macolino-Kane, John R. Ciallella,
Christopher A. Lipinski, and Andrew G. Reaume
Section III Drug Repositioning for
Nervous System Diseases
Chapter 8 A Case Study: Chlorpromazine
Francisco López-Munoz, Cecilio Álamo,
and Silvia E. García-Ramos
Chapter 9 Drug Repurposing for Central Nervous System Disorders: A
Pillar of New Drug Discovery
Mondher Toumi, Aleksandra Caban, Anna Kapüniak,
Szymon Jaros¿awski, and Cecile Rémuzat
Chapter 10 Repurposing Opportunities for Parkinson's Disease Therapies
Giulia Ambrosi, Silvia Cerri, and Fabio Blandini
Chapter 11 Drug Candidates for Repositioning in Alzheimer's Disease
Maria P. del Castillo-Frias and Andrew J. Doig
Chapter 12 Promising Candidates for Drug Repurposing in Huntington's
Disease
Francesca Romana Fusco and Emanuela Paldino
Chapter 13 Drug Repositioning Opportunities in Psychiatry
Alexander W. Charney, Joseph R. Scarpa, Douglas M. Ruderfer,
and Dennis S. Charney
Chapter 14 Pharmacology of Amyotrophic Lateral Sclerosis: Old Strategies
and New Perspectives
Tiziana Petrozziello, Valentina Tedeschi, Alba Esposito,
and Agnese Secondo
Chapter 15 Repositioning Clinic-Ready Compounds for the Treatment
of Spinal Muscular Atrophy
Faraz Farooq
Chapter 16 Rescuing Ischemic Brain Injury by Targeting the Immune
Response through Repositioned Drugs
Diana Amantea and Giacinto Bagetta
of Drug Repositioning
Chapter 1 Scientific and Commercial Value of Drug Repurposing
David Cavalla
Chapter 2 Repurposing for Alzheimer's and Parkinson's Diseases: The
Ideas, the Pipeline, the Successes, and the Disappointments
Hermann Mucke
Chapter 3 Contribution of Not-for-Profit Organizations to Drug Repurposing
Bruce Bloom
Section II Repositioning Approaches and
Technologies: From Serendipity to
Systematic and Rational Strategies
Chapter 4 Systematic Drug Repositioning
Spyros N. Deftereos, Aris Persidis, Andreas Persidis,
Eftychia Lekka, Christos Andronis, and Vassilis Virvillis
Chapter 5 Technical Tools for Computational Drug Repositioning
Francesco Napolitano
Chapter 6 RNAi Screening toward Therapeutic Drug Repurposing
Nichole Orr-Burks, Byoung-Shik Shim, Olivia Perwitasari,
and Ralph A. Tripp
Chapter 7 Phenotypic Screening
Christine M. Macolino-Kane, John R. Ciallella,
Christopher A. Lipinski, and Andrew G. Reaume
Section III Drug Repositioning for
Nervous System Diseases
Chapter 8 A Case Study: Chlorpromazine
Francisco López-Munoz, Cecilio Álamo,
and Silvia E. García-Ramos
Chapter 9 Drug Repurposing for Central Nervous System Disorders: A
Pillar of New Drug Discovery
Mondher Toumi, Aleksandra Caban, Anna Kapüniak,
Szymon Jaros¿awski, and Cecile Rémuzat
Chapter 10 Repurposing Opportunities for Parkinson's Disease Therapies
Giulia Ambrosi, Silvia Cerri, and Fabio Blandini
Chapter 11 Drug Candidates for Repositioning in Alzheimer's Disease
Maria P. del Castillo-Frias and Andrew J. Doig
Chapter 12 Promising Candidates for Drug Repurposing in Huntington's
Disease
Francesca Romana Fusco and Emanuela Paldino
Chapter 13 Drug Repositioning Opportunities in Psychiatry
Alexander W. Charney, Joseph R. Scarpa, Douglas M. Ruderfer,
and Dennis S. Charney
Chapter 14 Pharmacology of Amyotrophic Lateral Sclerosis: Old Strategies
and New Perspectives
Tiziana Petrozziello, Valentina Tedeschi, Alba Esposito,
and Agnese Secondo
Chapter 15 Repositioning Clinic-Ready Compounds for the Treatment
of Spinal Muscular Atrophy
Faraz Farooq
Chapter 16 Rescuing Ischemic Brain Injury by Targeting the Immune
Response through Repositioned Drugs
Diana Amantea and Giacinto Bagetta
Section I The Rationale and Economics
of Drug Repositioning
Chapter 1 Scientific and Commercial Value of Drug Repurposing
David Cavalla
Chapter 2 Repurposing for Alzheimer's and Parkinson's Diseases: The
Ideas, the Pipeline, the Successes, and the Disappointments
Hermann Mucke
Chapter 3 Contribution of Not-for-Profit Organizations to Drug Repurposing
Bruce Bloom
Section II Repositioning Approaches and
Technologies: From Serendipity to
Systematic and Rational Strategies
Chapter 4 Systematic Drug Repositioning
Spyros N. Deftereos, Aris Persidis, Andreas Persidis,
Eftychia Lekka, Christos Andronis, and Vassilis Virvillis
Chapter 5 Technical Tools for Computational Drug Repositioning
Francesco Napolitano
Chapter 6 RNAi Screening toward Therapeutic Drug Repurposing
Nichole Orr-Burks, Byoung-Shik Shim, Olivia Perwitasari,
and Ralph A. Tripp
Chapter 7 Phenotypic Screening
Christine M. Macolino-Kane, John R. Ciallella,
Christopher A. Lipinski, and Andrew G. Reaume
Section III Drug Repositioning for
Nervous System Diseases
Chapter 8 A Case Study: Chlorpromazine
Francisco López-Munoz, Cecilio Álamo,
and Silvia E. García-Ramos
Chapter 9 Drug Repurposing for Central Nervous System Disorders: A
Pillar of New Drug Discovery
Mondher Toumi, Aleksandra Caban, Anna Kapüniak,
Szymon Jaros¿awski, and Cecile Rémuzat
Chapter 10 Repurposing Opportunities for Parkinson's Disease Therapies
Giulia Ambrosi, Silvia Cerri, and Fabio Blandini
Chapter 11 Drug Candidates for Repositioning in Alzheimer's Disease
Maria P. del Castillo-Frias and Andrew J. Doig
Chapter 12 Promising Candidates for Drug Repurposing in Huntington's
Disease
Francesca Romana Fusco and Emanuela Paldino
Chapter 13 Drug Repositioning Opportunities in Psychiatry
Alexander W. Charney, Joseph R. Scarpa, Douglas M. Ruderfer,
and Dennis S. Charney
Chapter 14 Pharmacology of Amyotrophic Lateral Sclerosis: Old Strategies
and New Perspectives
Tiziana Petrozziello, Valentina Tedeschi, Alba Esposito,
and Agnese Secondo
Chapter 15 Repositioning Clinic-Ready Compounds for the Treatment
of Spinal Muscular Atrophy
Faraz Farooq
Chapter 16 Rescuing Ischemic Brain Injury by Targeting the Immune
Response through Repositioned Drugs
Diana Amantea and Giacinto Bagetta
of Drug Repositioning
Chapter 1 Scientific and Commercial Value of Drug Repurposing
David Cavalla
Chapter 2 Repurposing for Alzheimer's and Parkinson's Diseases: The
Ideas, the Pipeline, the Successes, and the Disappointments
Hermann Mucke
Chapter 3 Contribution of Not-for-Profit Organizations to Drug Repurposing
Bruce Bloom
Section II Repositioning Approaches and
Technologies: From Serendipity to
Systematic and Rational Strategies
Chapter 4 Systematic Drug Repositioning
Spyros N. Deftereos, Aris Persidis, Andreas Persidis,
Eftychia Lekka, Christos Andronis, and Vassilis Virvillis
Chapter 5 Technical Tools for Computational Drug Repositioning
Francesco Napolitano
Chapter 6 RNAi Screening toward Therapeutic Drug Repurposing
Nichole Orr-Burks, Byoung-Shik Shim, Olivia Perwitasari,
and Ralph A. Tripp
Chapter 7 Phenotypic Screening
Christine M. Macolino-Kane, John R. Ciallella,
Christopher A. Lipinski, and Andrew G. Reaume
Section III Drug Repositioning for
Nervous System Diseases
Chapter 8 A Case Study: Chlorpromazine
Francisco López-Munoz, Cecilio Álamo,
and Silvia E. García-Ramos
Chapter 9 Drug Repurposing for Central Nervous System Disorders: A
Pillar of New Drug Discovery
Mondher Toumi, Aleksandra Caban, Anna Kapüniak,
Szymon Jaros¿awski, and Cecile Rémuzat
Chapter 10 Repurposing Opportunities for Parkinson's Disease Therapies
Giulia Ambrosi, Silvia Cerri, and Fabio Blandini
Chapter 11 Drug Candidates for Repositioning in Alzheimer's Disease
Maria P. del Castillo-Frias and Andrew J. Doig
Chapter 12 Promising Candidates for Drug Repurposing in Huntington's
Disease
Francesca Romana Fusco and Emanuela Paldino
Chapter 13 Drug Repositioning Opportunities in Psychiatry
Alexander W. Charney, Joseph R. Scarpa, Douglas M. Ruderfer,
and Dennis S. Charney
Chapter 14 Pharmacology of Amyotrophic Lateral Sclerosis: Old Strategies
and New Perspectives
Tiziana Petrozziello, Valentina Tedeschi, Alba Esposito,
and Agnese Secondo
Chapter 15 Repositioning Clinic-Ready Compounds for the Treatment
of Spinal Muscular Atrophy
Faraz Farooq
Chapter 16 Rescuing Ischemic Brain Injury by Targeting the Immune
Response through Repositioned Drugs
Diana Amantea and Giacinto Bagetta